BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34729994)

  • 1. Risk of Atherosclerotic Cardiovascular Disease and Nonatherosclerotic Cardiovascular Disease Hospitalizations for Triglycerides Across Chronic Kidney Disease Stages Among 2.9 Million US Veterans.
    Soohoo M; Hashemi L; Hsiung JT; Moradi H; Budoff MJ; Kovesdy CP; Kalantar-Zadeh K; Streja E
    J Am Heart Assoc; 2021 Dec; 10(23):e022988. PubMed ID: 34729994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Low-Density Lipoprotein Cholesterol and Cardiovascular Disease Risk Across Chronic Kidney Disease Stages (Data from 1.9 Million United States Veterans).
    Hashemi L; Hsiung JT; Arif Y; Soohoo M; Jackson N; Gosmanova EO; Budoff M; Kovesdy CP; Kalantar-Zadeh K; Streja E
    Am J Cardiol; 2022 May; 170():47-55. PubMed ID: 35300833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum triglycerides and mortality risk across stages of chronic kidney disease in 2 million U.S. veterans.
    Soohoo M; Moradi H; Obi Y; Kovesdy CP; Kalantar-Zadeh K; Streja E
    J Clin Lipidol; 2019; 13(5):744-753.e15. PubMed ID: 31562050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD.
    Bajaj A; Xie D; Cedillo-Couvert E; Charleston J; Chen J; Deo R; Feldman HI; Go AS; He J; Horwitz E; Kallem R; Rahman M; Weir MR; Anderson AH; Rader DJ;
    Am J Kidney Dis; 2019 Jun; 73(6):827-836. PubMed ID: 30686529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Serum Triglycerides and Renal Outcomes among 1.6 Million US Veterans.
    Soohoo M; Hashemi L; Hsiung JT; Moradi H; Budoff MJ; Kovesdy CP; Kalantar-Zadeh K; Streja E
    Nephron; 2022; 146(5):457-468. PubMed ID: 35354153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trajectories of atherosclerotic cardiovascular disease risk scores as a predictor for incident chronic kidney disease.
    Lee HS; Lim HI; Moon TJ; Lee SY; Lee JH
    BMC Nephrol; 2024 Apr; 25(1):141. PubMed ID: 38649847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins, Mortality, and Major Adverse Cardiovascular Events Among US Veterans With Chronic Kidney Disease.
    Barayev O; Hawley CE; Wellman H; Gerlovin H; Hsu W; Paik JM; Mandel EI; Liu CK; Djoussé L; Gaziano JM; Gagnon DR; Orkaby AR
    JAMA Netw Open; 2023 Dec; 6(12):e2346373. PubMed ID: 38055276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between atherosclerotic cardiovascular diseases risk and renal outcome in patients with type 2 diabetes mellitus.
    Ren H; Zhao L; Zou Y; Wang Y; Zhang J; Wu Y; Zhang R; Wang T; Wang J; Zhu Y; Guo R; Xu H; Li L; Cooper ME; Liu F
    Ren Fail; 2021 Dec; 43(1):477-487. PubMed ID: 33685340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Prediction Models for Atherosclerotic Cardiovascular Disease in Patients with Chronic Kidney Disease: The CRIC Study.
    Bundy JD; Rahman M; Matsushita K; Jaeger BC; Cohen JB; Chen J; Deo R; Dobre MA; Feldman HI; Flack J; Kallem RR; Lash JP; Seliger S; Shafi T; Weiner SJ; Wolf M; Yang W; Allen NB; Bansal N; He J;
    J Am Soc Nephrol; 2022 Mar; 33(3):601-611. PubMed ID: 35145041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein(a) and the Risk for Recurrent Atherosclerotic Cardiovascular Events Among Adults With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Poudel B; Rosenson RS; Kent ST; Bittner V; Gutiérrez OM; Anderson AH; Woodward M; Jackson EA; Monda KL; Bajaj A; Huang L; Kansal M; Rahman M; He J; Muntner P; Colantonio LD;
    Kidney Med; 2023 Jul; 5(7):100648. PubMed ID: 37492110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender difference in the risk for cardiovascular events or mortality of patients with diabetic foot syndrome.
    Seghieri G; Policardo L; Gualdani E; Anichini R; Francesconi P
    Acta Diabetol; 2019 May; 56(5):561-567. PubMed ID: 30725263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trajectories of Blood Lipid Concentrations Over the Adult Life Course and Risk of Cardiovascular Disease and All-Cause Mortality: Observations From the Framingham Study Over 35 Years.
    Duncan MS; Vasan RS; Xanthakis V
    J Am Heart Assoc; 2019 Jun; 8(11):e011433. PubMed ID: 31137992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicted cardiovascular risk for United States adults with diabetes, chronic kidney disease, and at least 65 years of age.
    Jaeger BC; Sakhuja S; Hardy ST; Akinyelure OP; Bundy JD; Muntner P; Whelton PK
    J Hypertens; 2022 Jan; 40(1):94-101. PubMed ID: 34420013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of dietary fatty acids with the risk of atherosclerotic cardiovascular disease in a prospective cohort of United States veterans.
    Ivey KL; Nguyen XT; Li R; Furtado J; Cho K; Gaziano JM; Hu FB; Willett WC; Wilson PW; Djoussé L
    Am J Clin Nutr; 2023 Oct; 118(4):763-772. PubMed ID: 37479185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Statin Use With All-Cause and Cardiovascular Mortality in US Veterans 75 Years and Older.
    Orkaby AR; Driver JA; Ho YL; Lu B; Costa L; Honerlaw J; Galloway A; Vassy JL; Forman DE; Gaziano JM; Gagnon DR; Wilson PWF; Cho K; Djousse L
    JAMA; 2020 Jul; 324(1):68-78. PubMed ID: 32633800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National Lipid Association Scientific Statement on the use of icosapent ethyl in statin-treated patients with elevated triglycerides and high or very-high ASCVD risk.
    Orringer CE; Jacobson TA; Maki KC
    J Clin Lipidol; 2019; 13(6):860-872. PubMed ID: 31787586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of the Pooled Cohort atherosclerotic cardiovascular disease risk score in hepatitis C virus-infected persons.
    Chew KW; Bhattacharya D; Horwich TB; Yan P; McGinnis KA; Tseng C; Freiberg MS; Currier JS; Butt AA
    J Viral Hepat; 2017 Oct; 24(10):814-822. PubMed ID: 28273386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of ASCVD risk score for mortality and major adverse cardiovascular events in the year following a COVID-19 infection among US Veterans.
    Guardino ET; Tarko L; Wilson PWF; Gaziano JM; Cho K; Gagnon DR; Orkaby AR
    Int J Cardiol; 2023 Sep; 387():131120. PubMed ID: 37330018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of Incident Atherosclerotic Cardiovascular Disease Events and All-Cause Mortality in Patients With Age-Related Macular Degeneration: Prospective Cohort Study of UK Biobank.
    Wang Y; Liang Y; Seth I; Wu G; Du Z; Huang Y; Shang X; Liu S; Hu Y; Fang Y; Zhu Z; Hu Y; Zhang X; Yang X; Yu H
    Asia Pac J Ophthalmol (Phila); 2023 May-Jun 01; 12(3):293-302. PubMed ID: 37249901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin K Intake and Atherosclerotic Cardiovascular Disease in the Danish Diet Cancer and Health Study.
    Bellinge JW; Dalgaard F; Murray K; Connolly E; Blekkenhorst LC; Bondonno CP; Lewis JR; Sim M; Croft KD; Gislason G; Torp-Pedersen C; Tjønneland A; Overvad K; Hodgson JM; Schultz C; Bondonno NP
    J Am Heart Assoc; 2021 Aug; 10(16):e020551. PubMed ID: 34369182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.